DNTH

NASDAQ HEALTHCARE

Dianthus Therapeutics Inc.

$88.55

-$2.16 (-2.38%)

Live quote

52w: $32.22 – $117.88

Loading chart…

P/E Ratio—

P/B Ratio4.46

EV/EBITDA—

Debt/Equity—

ROE-13.85%

ROIC—

Revenue Growth-67.35%

Gross Margin—

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammatory diseases. The company is headquartered in New York, New York.

Own DNTH? Track it here.

Create a free account to add DNTH to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account